Reversible retinal vessel closure from VEGF-induced leukocyte plugging.

about

Recent advances in understanding and managing retinal vein occlusions.

P2860

Q55283872-D421E1E9-5A42-4F91-A434-C2A7CA712A32

P2860

Reversible retinal vessel closure from VEGF-induced leukocyte plugging.

Item

http://www.wikidata.org/entity/Q42367664

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Reversible retinal vessel closure from VEGF-induced leukocyte plugging.

@en

Reversible retinal vessel closure from VEGF-induced leukocyte plugging.

@nl

type

Item

label

Reversible retinal vessel closure from VEGF-induced leukocyte plugging.

@en

Reversible retinal vessel closure from VEGF-induced leukocyte plugging.

@nl

prefLabel

Reversible retinal vessel closure from VEGF-induced leukocyte plugging.

@en

Reversible retinal vessel closure from VEGF-induced leukocyte plugging.

@nl

P1476

Reversible retinal vessel closure from VEGF-induced leukocyte plugging.

@en

P2093

Jiangxia Wang

http://www.w3.org/2001/XMLSchema#string

Jikui Shen

http://www.w3.org/2001/XMLSchema#string

Peter A Campochiaro

http://www.w3.org/2001/XMLSchema#string

Seth D Fortmann

http://www.w3.org/2001/XMLSchema#string

Yuanyuan Liu

http://www.w3.org/2001/XMLSchema#string

P2860

VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR)

Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1

A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression

Nitric oxide in vascular biology

Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study

Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition

Leukocyte-mediated endothelial cell injury and death in the diabetic retina

P31

scholarly article

P356

10.1172/JCI.INSIGHT.95530

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dietmar Vestweber

P577

2017-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28931763

http://www.w3.org/2001/XMLSchema#string

P932

5621911

http://www.w3.org/2001/XMLSchema#string

Reversible retinal vessel closure from VEGF-induced leukocyte plugging.

about

P2860

P2860

Reversible retinal vessel closure from VEGF-induced leukocyte plugging.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932